| |  Mangalam Drugs & Organics Ltd. |

Country: India
Rupam Building, 3rd Floor, 239, P. D. Mello Road, Near G.P.O. Mumbai 400001 (INDIA)
| Phone: | (+91) 22 22616200 | Phone 2: | (+91) 22 22616300 | Phone 3: | (+91) 22 22618787 | FAX: | (+91) 22 22619090 | E-Mail: | E-Mail this Supplier |
Contact: Chetan Sarda
http://www.mangalamdrugs.com
|
|
Mangalam Drugs & Organics Limited commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and Intermediates at VAPI – Gujarat in 1977. It has a multi-product manufacturing facility on two locations, and an in-house Research & Development laboratory recognized by the Department of Scientific & Industrial Research, Delhi Govt. of India (DSIR).Over the last four decades, Mangalam has acquired worldwide reputation as a single stop destination for frontline Anti-malaria. We also have a diversified product range like Anti-retroviral, Anti-Viral, Anti Inflammatory, Rheumatic Arthritis Agent, Uricosuric, Anti– Convulsant, Anti-Hyperliporoteinemic, Anti – Hypertensive and Anti-Bacterial APIs. Mangalam is amongst the top companies in Asia in all the products it makes; and is also the largest manufacturer of some of its products in the world. Along with the WHO-GENEVA GMP Certification and EDQM approval for its API manufacturing plant, the company is also in an agreement with the prestigious Clinton Health Access Initiatives (CHAI) under its Fight Malaria Program for supply of anti-malaria APIs worldwide. |
Product List: 250
PON:Page:
|
| |
APIs | ACYCLOVIR (ACICLOVIR) [EP/IP] CAS:59277-89-3 Anti Viral | AMODIAQUINE HCL (USP / IP / IHT) CAS:6398-98-7 Anti-Malaria | ARTEMETHER (PH.INT. / IP) CAS:71963-77-4 Anti-Malaria | ARTESUNATE (PH.INT.) CAS:88495-63-0 Anti-Malaria | ATAZANAVIR SULFATE (PH. INT./ IP /IH) CAS:229975-97-7 Anti-retroviral | ATORVASTATIN CALCIUM (PH. EUR./IP) CAS:344423-98-9 Anti hyperlipoproteinemic | BISOPROLOL FUMARATE (PH.EUR. / BP / USP) CAS:104344-23-2 Antihypertensive | DIHYDROARTEMISININ (PH.INT.) CAS:71939-50-9 Anti-Malaria | DOLUTEGRAVIR SODIUM (IH) CAS:1051375-19-9 Antiretroviral activity | EFAVIRENZ (PH. INT. / IP / USP) CAS:154598-52-4 ANTIRETROVIRAL | EMTRICITABINE (PH. INT. / IP / USP FORUM) CAS:143491-57-0 ANTIRETROVIRAL | FUROSEMIDE (PH.EUR. / BP / USP / IP) CAS:54-31-9 Diuretic; Antihypertensive | HYDROXYCHLOROQUINE SULPHATE (PH.EUR. / BP / USP) CAS:747-36-4 Anti-Malaria | LUMEFANTRINE (PH.INT. / USP ) CAS:82186-77-4 Anti-Malaria | NIMESULIDE (PH.EUR. / BP) CAS:51803-78-2 Anti-inflammatory | NITROFURANTOIN ANHYDROUS (PH. EUR./USP) CAS:67-20-9 Anti Bacterial | NITROFURANTOIN MONOHYDRATE (PH. EUR./USP) CAS:17140-81-7 Anti Bacterial | PIPERAQUINE PHOSPHATE (IHT) CAS:4085-31-8 Anti-Malaria | PRIMAQUINE PHOSPHATE (PH. EUR. / IP / BP/ USP) CAS:63-45-6 Anti-Malaria | PYRIMETHAMINE (IH) CAS:58-14-0 Anti-Malaria | PYRONARIDINE TETRAPHOSPHATE (IHT) CAS:76748-86-2 Anti-Malaria | SULFADOXINE (IH) CAS:2447-57-6 Anti-Malaria | TENOFOVIR ALAFENAMIDE HEMIFUMARATE (IH) CAS:1392275-56-7 Antiretroviral and Hepatitis B | TENOFOVIR DISOPROXIL FUMARATE (PH.INT. / IP)OPEN CAS:202138-50-9 ANTIRETROVIRAL |
Intermediates | 4,7 DICHLOROQUINOLINE CAS:86-98-6 | ORTHO PHENOXY METHANE SULFONANILIDE CAS:51765-51-6 | TENOFOVIR ALAFENAMIDE BASE CAS:379270-37-8 | TENOFOVIR DISOPROXIL BASE CAS:201341-05-1 |
Speciality chemical | 2,3-DIHYDROPHTHALAZINE-1,4-DIONE OR PHTHALAZINE-1,4-DIONE CAS:20116-64-7 | 4-CYNOETHYL-2-METHYL PHENOL CAS:22516-99-0 | L(+)-MENTHOL CAS:2216-51-5 | META AMINO ACETANILIDE CAS:102-28-3 |
Impurities | | | CAS:Emtricitabine5-epimers(No.n/a) | CAS:EmtricitabineEnantiomer:no.137530-41-7+ | ((E)-9-(PROP-1-ENYL)-9H-PURIN-6-AMINE) | (+) –(S)- A-(2-CHLOROPHENYL)-6,7-DIHYDROTHIENO[3,2-C]PYRIDINE -5(4H)-ACETIC ACID HYDROCHLORIDE CAS:144750-42-5 | ({[(R) -1-(6-AMINO-9H-PURIN-9-YL) PROPAN-2-YLOXY] METHYL} (HYDROXY) PHOSPHORYLOXY) METHYL ISOPROPYL CARBONATE | (1) 2(1H)-PYRIMIDINONE, 4-AMINO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-, (2R-CIS)-; OR CAS:134678-17-4 | (2) (-)-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-CYTOSINE. (DES FLUORO EMTRICITABINE) | (2_S_,3_S_)-1,2-EPOXY-3-(BOC-AMINO)-4-PHENYL BUTANE OR (2S,3S)-BOC EPOXY OR BOC-EPOXY DIASTEREOMER IMPURITY CAS:98737-29-2 | (2R,5R)-5-HYDROXY-1,3-OXATHIOLANE-2-CARBOXYLIC ACID (1R,2S,5R)-5-METHYL-2-(1-METHYLETHYL)CYCLOHEXYL ESTER (HME) CAS:147126-62-3 | (2R,5S)-(1R,2S,5R)-2-ISO PROPYL-5-METHYLCYCLO HEXYL 5-(4-AMINO-2-OXO PYRIMIDIN-1(2H)-YL)-1,3-OXATHIOLANE-2-CARBOXYLATE (CME) CAS:147027-10-9 | (2S, 2'S)-DIISOPROPYL 2,2'-((((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHORYL)BIS(AZANEDIYL))DIPROPANOATE OR PMPA BISAMIDATE CAS:1883563-86-7 | (4-CHLOROPHENYL)(2-ETHYL-1,3-DIOXOLAN-2-YL)ACETONITRILE CAS:55474-41-4 | (4-CHLOROPHENYL)ACETONITRILE (4-CPA) CAS:140-53-4 | (4R,12AS)-N-(2-FLUOROBENZYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8, 12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5] PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXAMIDE OR 4-DES FLUORO DOLUTEGRAVIR CAS:- | (4R,12AS)-N-(4-FLUOROBENZYL)-7-METHOXY-4-METHYL-6,8-DIOXO-3,4,6,8, 12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5] PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXAMIDE OR 2-DES FLUORO METHOXY CAS:- | (4S,12AR)-N-(2,4-DIFLUOROBENZYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6 ,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5] PYRAZINO[2,1-B][1,3] OXAZINE-9-CARBOXAMIDE OR DOLUTEGRAVIR ENANTIOMER (S, R) CAS:- | (PS): DIASTEREOMER (PR) | (R)-()-3-(CARBAMOYL METHYL) -5-METHYL HEXANOIC ACID (R-CMH) CAS:181289-33-8 | (R)-()-3-(CARBAMOYL METHYL)-5-METHYL HEXANOIC ACID OR R-CMH SYSTEM SUITABILITY MIXTURE CAS:- | (R)-[1-(6-AMINO-9H-PURIN-9-YL) PROPAN-2-YLOXY] METHYLPHOSPHONIC ACID | (R)-2-AMINO-PROPIONIC ACID ISOPROPYL ESTER OR D-ALANINE ISOPROPYL ESTER HCL CAS:39613-92-8 | (R)-DIPHENYL (((1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONATE CAS:- | (RS)-1-(4-HYDROXYMETHYLPHENOXY)-3-ISOPROPYLAMINOPROPAN-2-OL CAS:62572-93-4 | (RS)-1-ISOPROPYLAMINO-3-[4-(2-PROPOXYETHOXYMETHYL)PHENOXY] PROPAN-2-OL CAS:- | (RS)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-1H-BENZO[D][1,3]OXAZINE-2(4H)-ONE | (S)-2-((METHOXYCARBONYL)AMINO)-3,3-DIMETHYLBUTANOIC ACID ORMETHOXYCARBONYL-L-TERT-LEUCINE OR MOC-L-TERT-LEUCINE ORATAZANAVIR RELATED COMPOUND A CAS:162537-11-3 | (S)-2-(2-AMINO-5-CHLOROPHENYL)-4-CYCLOPROPYL-1,1,1-TRIFLUOROBUT-3YN-2-OL | (S)-2-AMINO-PROPIONIC ACID ISOPROPYL ESTER OR L-ALANINE ISOPROPYL ESTER HCL CAS:62062-65-1 | (S)-2-AMINOPROPIONIC ACID OR L-A-AMINOPROPIONIC ACID OR L-ALANINE CAS:56-41-7 | (S)-ETHYL 4-CHLORO-2-(4-CYCLOPROPYL-1, 1, 1-TRIFLUORO-2-HYDROXYBUT-3-YN-2-YL) PHENYLCARBAMATE | (S)-ISOPROPYL 2-(((S)-((((S)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)(PHENOXY)PHOS CAS:- | (S)-METHYL 4-CHLORO-2-(4-CYCLOPROPYL-1,1,1-TRIFLUORO-2-HYDROXYBUT-3-YN-2-YL)PHENYL CARBAMATE | +)-3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID (CMH) CAS:181289-15-6 | [1,3] OXAZINE ACID IMPURITY OR (4R,12AS)-7-METHOXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO [1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXYLIC ACID CAS:1335210-34-8 | [1,3] OXAZINE AMIDE IMPURITY OR (4R,12AS)-N-(2,4-DIFLUOROBENZYL)-7-METHOXY-4,12A- CAS:1335210-35-9 | [2,1-B][1,3]OXAZINE-9-CARBOXAMIDE | [ADENINE] 9H-PURIN-6-AMINE CAS:73-24-5 | [TENOFOVIR DISOPROXIL CARBAMATE] CAS:1244022-54-5 | [TENOFOVIR DISOPROXIL ETHYL ESTER] CAS:- | [TENOFOVIR DISOPROXIL RELATED COMPOUND-B] CAS:4121-40-8 | [TENOFOVIR ISOPROPYL ISOPROXIL] CAS:1246812-40-7 | [TENOFOVIR ISOPROXIL MONOESTER] CAS:211364-69-1 | [TENOFOVIR] CAS:147127-20-6 | _TERT_-BUTYL 2-(4-(PYRIDIN-2-YL)BENZYL) HYDRAZINECARBOXYLATE (BOC HYDRAZINE) CAS:198904-85-7 | 1,4-BIS-(4,7-DICHLOROQUINOLINE)PIPERAZINE CAS:- | 1,4-DIBROMOPENTANE CAS:626-87-9 | 1-((2R,3R,4R,5R)-3-FLUORO-4-HYDROXY-5-(HYDROXYMETHYL)-3-METHYLTETRA HYDROFURAN-2~YL)PYRIM IDINE-2,4(1H,3H)-DIONE OR SFB URIDINE OR 2’-DEOXY-2’-FLUORO-2’-C-METHYLURIDINE CAS:817204-32-3 | 1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLANE-5-YL]PYRIMIDINE-2,4-(1H,3H)-DIONE OR LAMIVUDINE URIDINE ANALOGUE CAS:145986-07-8 | 1-[4-(PYRIDIN-2-YL)PHENYL]-5(S)-2,5-BIS{[N-(METHOXY-CARBONYL)-D-TERT-LEUCINYL]AMINO}-4(R)-HYDROXY-6-PHENYL-2-AZAHEXANE OR ATAZANAVIR DIASTEREOMER R, S, R, R OR (3R,8R,9S,12R)-ATAZANAVIR CAS:1292296-10-6 | 1-[4-(PYRIDIN-2-YL)PHENYL]-5(S)-2,5-BIS{[N-(METHOXY-CARBONYL)-D-TERT-LEUCINYL]AMINO}-4(S)-HYDROXY-6-PHENYL-2-AZAHEXANE OR ATAZANAVIR DIASTEREOMER R, S, S, R OR (3R,8S,9S,12R)-ATAZANAVIR CAS:1292296-11-7 | 1-[4-(PYRIDIN-2-YL)PHENYL]-5(S)-2,5-BIS{[N-(METHOXY-CARBONYL)-L-TERT-LEUCINYL]AMINO}-4(R)-HYDROXY-6-PHENYL-2-AZAHEXANE OR ATAZANAVIR DIASTEREOMER S, S, R, S OR 8-EPI ATAZANAVIR CAS:1292296-09-3 | 1-ETHYL-3-(3-DIMETHYLAMINOPROPYL)CARBODIIMIDE HYDROCHLORIDE (EDC.HCL) CAS:25952-53-8 | 1-ETHYL-3-(3-DIMETHYLAMINOPROPYL)CARBODIIMIDE (EDC) CAS:1892-57-5 | 1-METHYLETHYL (2RS)-2-HYDROXY-2-PHENYLACETATE CAS:4118-51-8 | 1H-BENZO[D][1,2,3]TRIAZOL-1-OL HYDRATE (HOBT MONOHYDRATE) CAS:123333-53-9 | 2, 3, 4, 5, 6-PENTAFLUOROPHENOLOR PENTAFLUORO PHENOL CAS:771-69-1 | 2,3-DIHYDROPHTHALAZINE-1,4-DIONE (PRIMAQUINE PHOSPHATE IMPURITY-2: SPECIFIED UNIDENTIFIED IMPURITY; RRT.-0.29) CAS:1445-69-8 | 2,4 DICHLORO-5-SULPHAMOYL BENZOIC ACID [LASAMIDE] CAS:2736-23-4 | 2,4-DI DESFLUORO METHOXY IMPURITY OR (4R,12AS)-N-BENZYL-7-HYDROXY-4,12A-DIMETHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXAMIDE CAS:- | 2,4-DICHLORO BENZOIC ACID (DCBA) CAS:50-84-0 | 2,4-DICHLOROBENZOIC ACID CAS:50-84-0 | 2,7-DICHLORO-4-FLUORENYL KETONE CAS:7012-16-0 | 2-(4-((6-METHOXYQUINOLIN-8-YL)AMINO)PENTYL)ISOINDOLINE-1,3-DIONE SULFATE [ISOINDOLINE-1,3-DIONE] CAS:- | 2-(4-BROMOPENTYL)ISOINDOLINE 1,3-DIONE OR 4-BROMO-1-PHTHALIMIDO PENTANE (4-BPP) CAS:59353-62-7 | 2-(4-CHLOROPHENYL)-3-OXOPENTANENITRILE CAS:55474-40-3 | 2-[[(4RS)-4-[(7-CHLOROQUINOLIN-4-YL)AMINO]PENTYL]-(ETHYL)AMINO]ETHYL HYDROGEN SULFATE OR IMPURITY B CAS:103152-84-7 | 2-[[2-(ACETYLAMINO)-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL]METHOXY]ETHYL ACETATE OR 9-[(2-ACETOXYETHOXY) METHYL]-N2-ACETYL GUANINE OR DIACETYL ACYCLOVIR OR IMPURITY-G CAS:75128-73-3 | 2-AMINO-1,7-DIHYDRO-6H-PURINE OR 2-AMINO-9H-PURIN-6 (1H)-ONE OR GUANINE OR IMPURITY-B CAS:73-40-5 | 2-AMINO-4-CHLORO-5-SULPHAMOYL BENZOIC ACID CAS:3086-91-7 | 2-CHLORO-1-(2,7-DICHLORO-9H-FLUOREN-4-YL)-ETHANONE CAS:- | 2-CHLORO-4-[(FURAN-2-YLMETHYL)AMINO]-5-SULPHAMOYL BENZOIC ACID OR CAS:4818-59-1 | 2-CHLORO-4-N-FURFURYLAMINO-5-SULFAMOYLBENZOIC ACID | 2-DESFLUORO HYDROXY IMPURITY OR (4R,12AS)-N-(4-FLUOROBENZYL)-7-HYDROXY-4,12A-DIMETHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXAMIDE CAS:- | 2-DIBUTYLAMINO-1-(2,7-DICHLORO-9H-FLUOREN-4-YL)-ETHANOL CAS:69759-61-1 | 2-PHENOXYANILINE CAS:2688-84-8 | 2RS, 5RS)-5-(4-AMINP-2-OXOPYRIMIDINE-1(2H)-YL)-1,3-OXATHIOLANE-2-CARBOXYLICACID OR LAMIVUDINE ACID IMPURITY CAS:173829-09-9 | 3-AMINO-4-CARBOXAMIDE PYRAZOLE HEMISULFATE (ASP) CAS:27511-79-1 | 3-MORPHOLOLINO-2-CYANOACRYLAMIDE (MCA) CAS:25229-97-4 | 4, 6-DICHLORO-5-METHOXY PYRIMIDINE CAS:5018-38-2 | 4,4’-[PIPERAZINE-1,4-DIYLBIS(PROPANE-3,1-DIYLPIPERAZINE-4,1-DIYL)]BIS(7-CHLOROQUINOLINE). CAS:86486-21-7 | 4,4’-PIPERAZINE-1,4-DIYLBIS(7-CHLOROQUINOLINE) CAS:- | 4,5-DICHLOROQUINOLINE CAS:21617-18-5 | 4,7-DICHLOROQUINOLINE CAS:86-98-6 | 4,7-DICHLOROQUINOLINE CAS:86-98-6 | 4,7-DICHLOROQUINOLINE | 4,7-DICHLOROQUINOLINE CAS:86-98-6 | 4-(2-PYRIDINYL)BENZALDEHYDE OR PYRIDINYL BENZALDEHYDE CAS:127406-56-8 | 4-(PYRIDIN-2-YL)BENZOIC ACID OR 4-(2-PYRIDYL)BENZOIC ACIDOR PYRIDINYL BENZOIC ACID CAS:4385-62-0 | 4-AMINO-5-FLUOROPYRIMIDIN-2(1H)-ONE (FLUORO CYTOSINE) CAS:2022-85-7 | 4-AMINO-N-(6-CHLORO-5-METHOXYPYRIMIDE-4-YL) BENZENESULFONAMIDE OR 4-AMINO-N-(6-CHLORO-5-METHOXY-4-PYRIMIDINYL) BENZENESULFONAMIDE CAS:5018-23-5 | 4-AMINOPYRIMIDIN-2(1H)-ONE OR CYTOSINE CAS:71-30-7 | 4-CHLORO BENZALDEHYDE CAS:104-88-1 | 4-CHLORO-2-[(6-METHOXYPYRIDIN-3-YL)AMINO]BENZOIC ACID (CMBA) CAS:- | 4-CHLORO-2-TRIFLUOROACETYL ANILINE HYDROCHLORIDE HYDRATE (KETO ANILINE OR E-2) CAS:173676-59-0 | 4-CHLORO-5-SULFAMOYLANTHRANILIC ACID CAS:3086-91-7 | 4-DESFLUORO METHOXY IMPURITY OR (4R,12AS)-N-(2-FLUOROBENZYL)-7-HYDROXY-4,12A-DIMETHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZINE-9-CARBOXAMIDE CAS:1863916-87-3 | 4-DIMETHYL AMINO PYRIDINE OR DIMETHYLAMINO PYIRIDINE CAS:1122-58-3 | 4-NITRO-2-PHENOXYPHENOL CAS:70995-08-3 | 4-PIPERAZIN-7-CHLORO-QUINOLINE CAS:- | 5,6-DIMETHOXYPYRIMIDIN-4-AMINE OR IMPURITY-D CAS:5018-45-1 | 5-(FORMYLAMINO)-1H-PYRAZOLE-4-CARBOXAMIDE CAS:22407-20-1 | 5-AMINO-1H-PYRAZOLE-4-CARBOXAMIDE CAS:5334-31-6 | 5-AMINO-2-METHOXY PYRIDINE (AMP) CAS:6628-77-9 | 5-CHLORO-4-(4-{3-[4-(7-CHLOROQUINOLIN-4-YL)PIPERAZIN-1-YL] PROPYL}PIPERAZIN-1-YL)QUINOLINE CAS:918879-09-1 | 5-CHLORO-4-HYDROXY QUINOLINE CAS:- | 5-FLUORO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL] URACIL (EMTRICITABINE 5-FLUORO URACIL ANALOG) CAS:145986-11-4 | 6-DESFLUORO BICTEGRAVIR FREE ACID (GS-626446) OR (2R,5S,13AR)-N-(2,4-DIFLUOROBENZYL)-8-HYDROXY-7,9-DIOXO-2,3,4,5, 7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B] [1,3]OXAZEPINE-10-CARBOXAMIDE CAS:- | 6-METHOXY-8-AMINO QUINOLINE (PRIMAQUINE PHOSPHATE IMPURITY-1: SPECIFIED UNIDENTIFIED IMPURITY; RRT.-0.24) CAS:90-52-8 | 7,10-DICHLORO-2-METHOXY-5,10-DIHYDROBENZO[B]-1,5-NAPHTHYDINE (DCNM) CAS:- | 7-CHLORO-4-(4-{3[(7-CHLOROQUINOLIN-4-YL)OXY]PROPYL} PIPERAZIN-1-YL)QUINOLINE CAS:1233345-93-1 | 7-CHLORO-4-(4-HYDROXY PHENYL AMINO)-QUINOLINE CAS:- | 7-CHLORO-4-[(2RS)-2-METHYLPYRROLIDIN-1-YL)QUINOLINE OR IMPURITY F CAS:6281-58-9 | 7-CHLORO-4-[4-(3-CHLOROPROPYL)PIPERAZIN-1-YL]QUINOLINE CAS:4038-99-7 | 7-CHLORO-4-{4-[3-(PIPERAZIN-1-YL)PROPYL]PIPERAZIN-1-YL}QUINOLINE CAS:4039-00-3 | 7-CHLORO-4-ETHOXY QUINOLINE CAS:5448-52-2 | 7-CHLORO-4-PIPERAZINYL QUINOLINE CAS:837-52-5 | 7-CHLOROQUINOLIN-4-OL CAS:86-99-7 | A - ARTEMETHER CAS:71939-51-0 | ACYCLOVIR* | ALLOPURINOL | AMODIAQUINE HYDROCHLORIDE* | ARTEMETHER*/ARTESUNATE*/DIHYDROARTEMISININ* | ARTEMISININ CAS:63968-64-9 | ATAZANAVIR SULFATE* | BENZOIC ACID, 2-HYDROXY-. (SALICYLIC ACID) CAS:69-72-7 | BICTEGRAVIR AMIDE OR METHYL 1-(2,2-DIMETHOXYETHYL)-3-METHOXY-4-OXO-5-((2,4,6-TRIFLUOROBENZYL)CARBAMOYL)-1,4-DIHYDROPYRIDINE-2-CARBOXYLATE CAS:1644158-10-0 | BICTEGRAVIR DIHYDROXY OR METHYL 1-(2,2-DIHYDROXYETHYL)-3-METHOXY-4-OXO-5-((2,4,6-TRIFLUOROBENZYL)CARBAMOYL)-1,4-DIHYDROPYRIDINE-2-CARBOXYLATE CAS:- | BICTEGRAVIR METHOXY OR (2R,5S,13AR)-8-METHOXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE - | BICTEGRAVIR SODIUM* | BICTEGRAVIR SYSTEM SUITABILITY MIXTURE (BICTEGRAVIR SODIUM AND GS-652240) CAS:- | BIS ISOINDOLINE-1,3 DIONE IMPURITY OR 2,2'-(PENTANE-1,4-DIYL)BIS(ISOINDOLINE-1,3-DIONE) CAS:- | BIS((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)DIPHOSPHONIC ACID CAS:- | BISOPROLOL FUMARATE* | BOC-HYDRAZINE OR BOC-HYDRAZINE (N-1 IMPURITY) | CIS-5-[4-AMINO-5-FLUORO-2-OXOPYRIMIDIN-1(2H)-YL]-1,3-OXATHIOLANE-2-CARBOXYLIC ACID (EMTRICITABINE ACID) CAS:1238210-10-0 | CLOPIDOGREL BISULPHATE* | DESMETHYL TENOFOVIR DISOPROXIL OR CAS:365417-53-4 | DIACETAL-3-CARBOXYLIC ACID IMPURITY OR 1-(2,2-DIMETHOXYETHYL)-5-METHOXY-6-(METHOXYCARBONYL)-4-OXO- 1,4-DIHYDROPYRIDINE-3-CARBOXYLIC ACID CAS:1335210-23-5 | DIHYDROARTEMISININ CAS:81496-81-3 | DIMETHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO[1',2':4,5]PYRAZINO | DOLUTEGRAVIR SODIUM* | DOLUTEGRAVIR SODIUM* | EFAVIRENZ AMINO ALCOHOL (EFAVIRENZ AMINO CARBINOL) OR CAS:209414-27-7 | EFAVIRENZ AMINO ALCOHOL BIS(ETHOXYCARBONYL)OR (S)-ETHYL 4-CHLORO-2-(4-CYCLOPROPYL-2-(ETHOXYCARBONYLOXY)-1, 1, 1-TRIFLUOROBUT-3-YN-2-YL) PHENYLCARBAMATE CAS:- | EFAVIRENZ AMINO ALCOHOL ETHYL CARBAMATE OR CAS:- | EFAVIRENZ AMINO ALCOHOL METHYL CARBAMATE OR CAS:211563-41-6 | EFAVIRENZ BENZOYL AMINO ALCOHOL OR (S)-N-(4-CHLORO-2-(4-CYCLOPROPYL-1, 1, 1-TRIFLUORO-2-HYDROXYBUT-3-YN-2-YL) PHENYL)-4-METHOXY BENZAMIDE CAS:- | EFAVIRENZ* | EMTRICITABINE SYSTEM SUITABILITY MIXTURE A (AS PER USP) OR CAS:Emtricitabine: | EMTRICITABINE* | ETHYL-(E/Z)-3-(2-CARBETHOXY-2-CYANOETHENYL)-AMINO-1H-PYRAZOLE-4-CARBOXYLATE CAS:321571-07-7 | ETHYL-5-(FORMYLAMINO)-1H-PYRAZOLE-4-CARBOXYLATE CAS:31055-19-3 | ETHYL-5-AMINO-1H-PYRAZOLE-4-CARBOXYLATE CAS:103259-35-4 | FUROSEMIDE* | HYDROXYCHLOROQUINE SULPHATE* | ISOPROPYL ((S)-(PERTLUOROPHENOXY)(PHENOXY)PHOSPHORYI)-L-ALANINATE OR SFB-C OR N-[(S)-(2,3,4,5,6-PENTAFLUOROPHENOXY)PHENOXYPHOSPHINYL]-L-ALANINE-1-METHYLETHYL ESTER CAS:1334513-02-8 | ISOPROPYL ((S)-2-(((2R,3R,4R,5R)-5-(2,4-DIOXO~3 ,4-DLHYDROPYRLMIDIN- 1 (2H)-YL )-4-FLUORO~2-((((S)-(((S)- 1 -I SOPROPOXY-1 -OXOPROPAN-2- YL)AMINO)(PHENOXY) PHOSPHORYL)OXY)METHYL)-4-METHYLTETRAHYDROFURAN- 3-YL)OXY) (PHENOXY)PHOSPHORY1)-L-A1ANINATE OR SFB D CAS:1337482-17-3 | L-MENTHYL 5-(2R,5S)-[4-AMINO-5-FLUORO-2-OXOPYRIMIDIN-1(2H)-YL]-1,3-OXATHIOLANE-2-CARBOXYLATE (F-CME) CAS:764659-72-5 | LACTUM IMPURITY OR (4S)-4-(2-METHYLPROPYL)PYRROLIDIN-2-ONE CAS:61312-87-6 | LAMIVUDINE* | LUMEFANTRINE* | MANDELIC ACID IMPURITY OR (2RS)-2-HYDROXY-2-PHENYLACETIC ACID CAS:90-64-2 | METHYL (+) A-(2-CHLOROPHENYL)-4,5-DIHYDROTHIENO[2,3-C]PYRIDINE -6(7H)-ACETATE. HYDROCHLORIDE CAS:144750-52-7 | METHYL (-) –(R)-A-(2-CHLOROPHENYL)-6,7-DIHYDROTHIENO[3,2-C]PYRIDINE -5(4H)-ACETATE. HYDROGEN SULFATE CAS:120202-71-3 | MIXTURE OF DIASTEREOMERS OF 4-[(7-CHLOROQUINOLIN-4-YL)AMINO]-N-ETHYL-N-(HYDROXYETHYL) PENTAN-1-AMINE N-OXIDE ORIMPURITY A CAS:- | MIXTURE OF EMTRICITABINE (5-FLUORO-1-[(2S,5R)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE) + EMTRICITABINE ENANTIOMER (5-FLUORO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE)+ EMTRICITABINE 5-EPIMERS OR EMTRICITABINE DIASTEREOMERS [ENTRIC CAS:no. 143491-57-0+ | N'-(4-PYRIDIN-2-YL-BENZYLIDENE)-HYDRAZINECARBOXYLIC ACID _TERT_-BUTYL ESTER OR _TERT_-BUTYL [[4-(2-PYRIDINYL)PHENYL]METHYLENE]HYDRAZINECARBOXYLATE OR IMPURITY-A OF CAS:198904-84-6 | N,N’-(BIS METHYLSULFONYL)-2-PHENOXY ANILINE CAS:- | N,N’-(BIS METHYLSULFONYL)-2-PHENOXY-4-NITRO ANILINE CAS:51765-72-1 | N-(2,4-DINITRO-6-PHENOXYPHENYL)-METHANESULPHONAMIDE CAS:- | N-(2-PHENOXYPHENYL)-METHANESULPHONAMIDE CAS:51765-51-6 | N-(4-(N-(5,6-DIMETHOXYPYRIMIDIN-4-YL) SULFAMOYL)PHENYL)ACETAMIDE OR IMPURITY-C CAS:5018-54-2 | N-(4-HYDROXYPHENYL)-ACETAMIDE [PARACETAMOL] CAS:8/1/8055 | N-(7-CHLOROQUINOLIN-4-YL)-N’-{3-[4-(7-CHLOROQUINOLIN-4-YL) PIPERAZIN-1-YL]PROPYL}ETHANE-1,2-DIAMINE CAS:- | N-(9-ACETYL-6-OXO-6,9-DIHYDOR-1H-PURIN-2-YL)ACETAMIDE (N2, 9-DIACETYL GUANINE) OR DIACETYL GUANINE OR IMPURITY-L CAS:3056-33-5 | N-[4-HYDROXY-3,5-BIS(PYRROLIDIN-1-YL METHYL) PHENYL]ACETAMIDE (HPPA) CAS:- | N-{3-[(DIETHYLAMINO)METHYL]-4-HYDROXYPHENYL}-ACETAMIDE CAS:- | N-BENZYL EFAVIRENZ OR (S)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-1-(4-METHOXYBENZYL)-4-(TRIFLUOROMETHYL)-2H-3,1-BENZOXAZIN-2-ONE CAS:174819-21-7 | NIMESULIDE* | O, O-BIS (ISOPROPOXYCARBONYLOXYMETHYL){(R)-1-[(6-ISOPROPOXYCARBONYL AMINO)-9H-PURIN-9YL] PROPAN-2-YLOXY]}METHYLPHOSPHONATE | O,O-BIS (ISOPROPYLCARBONYLOXYMETHYL) [(6-AMINO-9H-PURIN-9YL)ETHYLOXY]METHYL PHOSPHONATE | O-(ETHOXYCARBONYLOXYMETHYL)-O-(ISOPROPOXYCARBONYLOXYMETHYL)-{(R)-[1-(6-AMINO-9H-PURIN-9-YL) PROPAN-2-YLOXY]}METHYLPHOSPHONATE | O-(ISOPROPOXYCARBONYLOXYMETHYL)-O-ISOPROPYL-{(R)-[1-(6-AMINO-9H-PURIN-9-YL) PROPAN-2-YLOXY]}METHYLPHOSPHONATE | OPEN RING BICTEGRAVIR FREE ACID (GS-649086) OR 9-HYDROXY-2-((1S,3R)-3-HYDROXY CYCLOPENTYL)-1,8-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,8-DIHYDRO-1H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDE CAS:- | OR BISPHENYL PMPA | OR PMPA ANHYDRIDE | P-((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)-N-((S)-1-ISOPROPOX CAS:- | P-TOLUENE SULFONIC ACID MONOHYDRATE (PTSA) OR 4-METHYLBENZENE SULFONIC ACID CAS:6192-52-5 | PHENOL OR BENZENOL CAS:108-95-2 | PHENYL HYDROGEN ((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONATE OR MONOPHENYL PMPA CAS:379270-35-6 | PHORYL)AMINO)PROPANOATE OR TAF DIASTEREOMER 1 | PIPERAQUINE PHOSPHATE* | POTASSIUM PHTHALIMIDE CAS:1074-82-4 | PREGABALIN ENANTIOMER OR (3R)-3-(AMINO METHYL)-5-METHYLHAXANOIC ACID CAS:148553-51-9 | PREGABALIN RACEMIC MIXTURE OR 3-(AMINO METHYL)-5-METHYLHAXANOIC ACID CAS:128013-69-4 | PREGABALIN* | PRIMAQUINE PHOSPHATE | PYRIMETHAMINE* | PYRIMIDINE-2,4-(1H, 3H)-DIONE OR URACIL CAS:66-22-8 | PYRONARIDINE TETRAPHOSPHATE* | QUINOLINE ANALOG OR 6-CHLORO-2-CYCLOPROPYL-4-(TRIFLUOROMETHYL)QUINOLINE CAS:391860-73-4 | RACEMIC MIXTURE (DL) OF METHOXY CARBONYL-L-TERT-LEUCINE OR METHOXY CARBONYL-DL-TERT-LEUCINE CAS:- | RACEMIC MIXTURE OF (S) 3-AMINO-1-BUTANOL : (R) 3-AMINO-1-BUTANOL CAS:- | RACEMIC MIXTURE OF DOLUTEGRAVIR [R,S] AND DIASTEREOMER [R,R] CAS:- | SOFOSBUVIR* | SULFADOXINE* | SULFANILAMIDE OR 4-AMINOBENZENESULFONAMIDE CAS:63-74-1 | TAF (PS): (S)-ISOPROPYL 2-(((S)-((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)(PHENOXY)PHOSPHORYL)AMINO)PROPANOATE : DIASTEREOMER (PR): (S)-ISOPROPYL 2-(((R)-((((R)-1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)(PHENOXY)PHOSPHORYL)AMINO)PROPANO CAS:- | TENOFOVIR ALAFENAMIDE HEMIFUMARATE* | TENOFOVIR ALAFENAMIDE SYSTEM SUITABILITY MIXTURE OR TENOFOVIR ALAFENAMIDE CAS:- | TENOFOVIR DISOPROXIL FUMARATE* | TENOFOVIR DISOPROXIL IMPURITY A OR TENOFOVIR RELATED COMPOUND A OR (S)-5-[[2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYL]-2,4,6,8-TETRAOXA-5-PHOSPHANONANEDIOIC ACID, BIS (1-METHYLETHYL) ESTER, 5-OXIDE, (E)-2-BUTENEDIOATE (1:1). OR S-ISOMER OF TENOFOVIR CAS:- | TERT-BUTYL ((S)-1-((R)-OXIRAN-2-YL)-2-PHENYLETHYL)CARBAMATE (BOC EPOXY) CAS:98760-08-8 | TERT-BUTYL 2-((2S,3S)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-4-PHENYLBUTYL) -2-(4-(PYRIDIN-2-YL)BENZYL)HYDRAZINECARBOXYLATE OR DES-N-(METHOXYCARBONYL)-L-TERT-LEUCINE-BIS BOC ATAZANAVIR ORATAZANAVIR DI-TERT-BUTYL ANALOG CAS:198904-86-8 | USP EFAVIRENZRACEMIC MIXTURE RS OR CAS:177530-93-7 | Y-1-OXOPROPAN-2-YL)PHOSPHONAMIDIC ACID OR PMPA MONOAMIDATE |
|
|
|